Research Article
Efficacy and Safety of Trastuzumab Combined with Pertuzumab for Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer: A Meta-Analysis Study of Randomized Control Trials
Figure 3
Meta-analysis comparison of the progression-free survival after treatment between the two groups. (a) Forest plot. (b) Sensitivity analysis.
(a) |
(b) |